Search CMI

Note: the documents on this web site are PDF files. If you do not have a PDF reader, you can download one now.

Brand Name: the name given to the medicine by the company that makes the medicine. There may be more than one brand name if more than one company makes the medicine.

IMPORTANT INFORMATION

Reading the CMI does not take the place of counselling by a health professional. Always talk to your doctor or pharmacist about all aspects of your medicines, including why you are taking them and what benefits / risks you can expect.
The CMI for your medicine that is on this web site is the most up-to-date version available. It may differ from a CMI that you previously received from your doctor or pharmacist, or in your pack of medicine.

This web site does not contain all CMIs for medicines sold in Australia and not all medicines have a CMI available for them. If you do not find a CMI for your medicine on this page, contact the pharmaceutical company who makes the medicine or talk to your doctor or pharmacist. The information on this web site is intended for use in Australia only.

Product name	Date released
Abacavir/Lamivudine Viatris 12 Jan 2023   Do not use if you have ever had an allergic reaction to abacavir or lamivudine or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use ABACAVIR/LAMIVUDINE VIATRIS? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Abevmy 19 May 2023   ABEVMY is used to treat; brain tumours resistant to previous treatments metastatic (spreading) cancer of the large bowel (i.e. in the colon or rectum), breast or cervix in combination with chemotherapy agents lung cancer and cancer of the ovaries and fallopian tubes (which can extend to the lining of surrounding organs such as stomach, liver) in combination with chemotherapy agents kidney cancer (renal cell cancer) in combination with interferon therapy (Roferon-A®). ABEVMY contains the active ingredient bevacizumab. ABEVMY belongs to a group of medicines known as anti-neoplastic (or anti-cancer) agents. There are many different classes of anti- neoplastic agents. ABEVMY belongs to a class known as anti-angiogenic agents. Anti-angiogenic agents inhibit angiogenesis (the process of forming new blood vessels in your body). ABEVMY selectively binds to vascular endothelial growth factor (VEGF), a protein found on the cells that line blood vessels. Tumours produce high levels of VEGF, which stimulates blood vessels to grow, thereby providing the tumour with nutrients and oxygen. When ABEVMY blocks VEGF it disrupts the blood supply to the tumour, stopping or slowing down its growth. There are many different types of medicines used to treat brain tumours and metastatic cancer of the large bowel, breast, lung, kidney and cervix. Your doctor may have prescribed ABEVMY for another purpose. Ask your doctor if you have any questions about why ABEVMY has been prescribed for you. This medicine is not addictive. This medicine is available only with a doctor's prescription. read more Download PDF Standard Print Download PDF Large Print
Abilify 31 Oct 2022   Do not use if you have ever had an allergic reaction to ABILIFY or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use ABILIFY? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Abilify Maintena Therapeutic Kit 01 Jul 2021   Abilify Maintena should only be given by a healthcare professional. Do not receive if you have ever had an allergic reaction to aripiprazole or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use Abilify Maintena? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Abisart 24 Mar 2023   Do not use if you have ever had an allergic reaction to ABISART or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I take ABISART? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Abisart HCTZ 27 Mar 2023   Do not take if you have ever had an allergic reaction to ABISART HCTZ or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I take ABISART HCTZ? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Abraxane 27 Jun 2023   Do not use if you have ever had an allergic reaction to paclitaxel or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant (for males, if your partner plans to become pregnant) or are breastfeeding. For more information, see Section 2. What should I know before I use ABRAXANE? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Abrysvo 26 Mar 2024   You should not be given ABRYSVO if you have ever had an allergic reaction to ABRYSVO or any of the ingredients listed at the end of the CMI. Tell your healthcare professional if you have or have had an allergic reaction after being given any other vaccine in the past, bleeding problems, have an infection with a high fever, anxiety or fainting following any needle injections or a weakened immune system. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I am given ABRYSVO? in the full CMI. read more Download PDF Standard Print Download PDF Large Print Audio under revision, check back soon
Abstral sublingual tablets 04 Aug 2020   Do not take if you have ever had an allergic reaction to fentanyl or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I take ABSTRAL? in the full CMI. read more Download PDF Standard Print Download PDF Large Print
Abyraz 19 Jul 2022   Do not use if you have ever had an allergic reaction to ABYRAZ or any of the ingredients listed at the end of the CMI. Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding. For more information, see Section 2. What should I know before I use ABYRAZ? in the full CMI. read more Download PDF Standard Print Download PDF Large Print

Second tab content goes here.